Midodrine Tablets
indicated to manage symptomatic hypotension, utilizing pharmacological action to alleviate dizziness by elevating systemic vascular resistance.
Strengths: 2.5mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Bramox; Gutron
- Therapeutic class
Alpha-Adrenergic Agonist
- Pharmacological class
Sympathomimetic
- Precautions and warnings
monitor blood pressure in supine position; avoid taking at bedtime
- Minor side effects
piloerection; pruritus; urinary urgency
- Moderate side effects
hypertension; headache
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Takeda
- Onset Time
30 minutes
- Duration
3–4 hours
- Storage instructions
Store in a cool, dry place.
- Drug interactions
sympathomimetics; antihypertensives
- Age restrictions
Not established in children.
Contraindications
severe organic heart disease; severe hypertension; pheochromocytoma; urinary retention; acute renal failure
Serious side effects
bradycardia — requires immediate medical attention; arrhythmia — requires immediate medical attention
Patient summary
indicated to manage symptomatic hypotension, utilizing pharmacological action to alleviate dizziness by elevating systemic vascular resistance.
Mechanism of action
A selective alpha-1 adrenergic receptor agonist that acts on the peripheral vasculature to cause vasoconstriction, thereby increasing blood pressure in individuals with orthostatic hypotension.
Pregnancy and breastfeeding
Pregnancy: Use with caution only if benefits outweigh risks. Breastfeeding: Data is insufficient; caution advised.
Midodrine Tablets
indicated to manage symptomatic hypotension, utilizing pharmacological action to alleviate dizziness by elevating systemic vascular resistance.
Editorial Notes
- Active ingredient(s): Midodrine
- Listed indication(s): Hypotension
Available option
- 60 tablets - 2.5 mg1248-2-5-mg-14896